Pain Descriptions May Predict Presence of Neuropathic Pain

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 5 No 10
Volume 5
Issue 10

BUFFALO, NY-Just by looking at the words cancer pain patients used to describe their pain, researchers were able to correctly predict in 66% of cases which patients had neuropathic pain, Dr. Thomas Sist, of the Roswell Park Cancer Institute, said in his poster presentation at the 8th World Congress on Pain.

BUFFALO, NY-Just by looking at the words cancer pain patientsused to describe their pain, researchers were able to correctlypredict in 66% of cases which patients had neuropathic pain, Dr.Thomas Sist, of the Roswell Park Cancer Institute, said in hisposter presentation at the 8th World Congress on Pain.

The study involved a group of patients with cancer or chronicbenign pain seen at the Roswell Park Pain Clinic. According toan independent clinical assessment, 122 had exclusively somaticpain, 41 visceral pain, and 42 neuropathic pain. Patients withmixed pain syndromes were excluded from the study.

When these diagnoses were compared with the patients' answerson the McGill Pain Questionnaire, the researchers found that thepercentage of sensory words chosen to describe the pain was significantlyhigher for the neuropathic pain patients than for those with somaticand visceral pain.

"Patients with neuropathic pain were much more likely touse words like shooting, flashing, pricking, drilling, stabbing,sharp, and cutting-words that describe very distinct short-termphasic kinds of pain," Dr. Sist said.

Also, as would be expected, the neuropathic pain patients oftenused words suggesting a causalgic kind of pain, such as hot, burning,scalding, searing, smarting, and stinging.

"In fact, the hot, burning, scalding, searing words werethe ones that, of all the words listed, most assuredly predictedthe presence of neuropathic pain," he said.

Dr. Sist noted that the findings will be the basis for a largerstudy that will try to relate word selection more precisely toclinical findings, "the goal being to eventually providethe physician with some predictive capability when making paindiagnoses."

Recent Videos
Endobronchial ultrasound, robotic bronchoscopy, or other expensive procedures may exacerbate financial toxicity for patients seeking lung cancer care.
Destigmatizing cancer care for incarcerated patients may help ensure that they feel supported both in their treatment and their humanity.
Patients with mediastinal lymph node involved-lung cancer may benefit from chemoimmunotherapy in the neoadjuvant setting.
2 experts are featured in this series.
Advancements in antibody drug conjugates, bispecific therapies, and other targeted agents may hold promise in lung cancer management.
A lower percentage of patients who were released within 1 year of incarceration received guideline-concurrent care vs incarcerated patients.
Stressing the importance of prompt AE disclosure before they become severe can ensure that a patient can still undergo resection with curative intent.
A collaboration between the Connecticut Departments of Health and Corrections and the COPPER Center aimed to improve outcomes among incarcerated patients.
Thomas Marron, MD, PhD, presented a session on clinical data that established standards of care for stage II and III lung cancer treatment at CFS 2025.
Related Content